Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2009 February;57(1) > Minerva Cardioangiologica 2009 February;57(1):103-15

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS  VASCULAR INTERVENTIONS 2009 

Minerva Cardioangiologica 2009 February;57(1):103-15

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage

Majunke N. 1, Wallenborn J. 1, Wunderlich N. 1, Sievert H. 1, 2

1 CardioVascular Center Frankfurt Frankfurt, Germany 2 Washington Hospital Center Washington, DC, USA


PDF


Intracardiac defects such as atrial septal defect (ASD) and patent foramen ovale (PFO) are common forms of congenital intracardiac apertures which can be successfully closed percutaneously. Since the initial description of an atrial septal defect closure device in the mid 1970s by King and Mills, transcatheter closure of atrial septal defects and patent foramen ovale using various devices has now become an established practice in many centers. The left atrial appendage is a trabeculated remnant of the embryonic left atrium. This is an important source of emboli related to atrial fibrillation. Closure of the left atrial appendage is designed to reduce the risk of stroke in patients with atrial fibrillation. This article reviews the current indications and latest developments in catheter closure of PFO, ASD and left atrial appendage.

top of page